| Product No | EMEA/H/C/000143 |
|---|---|
| Brand Name | Liprolog |
| Nonproprietary Name | insulin lispro |
| API | insulin lispro |
| ATC Code | A10AB04 |
| Indications | For the treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Liprolog is also indicated for the initial stabilization of diabetes mellitus. Liprolog is a short acting insulin and may be used in conjunction with a longer acting human insulin. Liprolog is indicated for preprandial administration. |
| Orphan Drug | no |
| Generics | no |
| Marketing Authorization Holder | Eli Lilly and Company Limited |
| Status | Withdrawn |
| Authorization Date | 1997-05-07 |
| Version | 0 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information